Takeda withdraws application for dengue vaccine from FDA
Takeda announced that it has voluntarily withdrawn its application to the FDA for its dengue vaccine, making it unclear when or if the vaccine will be licensed in this country.
Takeda announced Tuesday that it has voluntarily withdrawn its application to the Food and Drug Administration for its dengue vaccine, making it unclear when or if the vaccine will be licensed in this country.
The company said in a press release that it will review whether to proceed with trying to bring the vaccine to the U.S. market. The vaccine has already been approved in the European Union, the United Kingdom, Brazil, Argentina, Indonesia, and Thailand.
What's Your Reaction?
